Carcinoma, Bronchogenic  >>  Inlyta (axitinib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inlyta (axitinib) / Pfizer
NCT00094094 / 2005-003501-90: Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer

Completed
2
32
US, Europe
axitinib
Pfizer
Lung Neoplasms, Carcinoma, Non-small Cell Lung
07/07
07/07
NCT00600821 / 2007-006682-33: A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Checkmark As first-line therapy for pts with adv NSCLC
Dec 2013 - Dec 2013: As first-line therapy for pts with adv NSCLC
Checkmark P2 data-ESMO
Sep 2012 - Sep 2012: P2 data-ESMO
Completed
2
118
US, Europe
Bevacizumab, Avastin, Carboplatin, Paclitaxel, AG-013736 (axitinib), axitinib Taxol
Pfizer
Non-Small-Cell Lung Carcinoma, Adenocarcinoma
04/11
10/12
NCT00735904 / 2008-001726-13: Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer

Completed
2
38
Europe, RoW
AG-013736, axitinib, gemcitabine, cisplatin
Pfizer
Carcinoma, Non-Small-Cell Lung (NSCLC)
11/11
11/11
NCT00386555: A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.

Withdrawn
2
0
US
docetaxel, CP-868,596 + docetaxel, AG-013736 + docetaxel, CP-868,596 + AG-013736 + docetaxel
Arog Pharmaceuticals, Inc.
Carcinoma, Non-Small-Cell Lung
 
 
NCT00768755 / 2008-004009-32: Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer

Checkmark Pemetrexed/cisplatin with or without axitinib for non-squamous NSCLC
Apr 2014 - Apr 2014: Pemetrexed/cisplatin with or without axitinib for non-squamous NSCLC
Checkmark P2 data-ASCO
Jun 2012 - Jun 2012: P2 data-ASCO
Completed
1/2
180
Japan, US, Europe, RoW
axitinib, AG-013736, chemotherapy, alimta
Pfizer
Carcinoma, Non-Small Cell Lung
03/11
03/12

Download Options